SC 13D/A | 2023-12-27 | SILBER ALLAN C | POINT Biopharma Global Inc. | 0 | 0.0% | EDGAR |
SC 13D/A | 2023-12-20 | BIOTECHNOLOGY VALUE FUND L P | POINT Biopharma Global Inc. | 0 | 0.0% | EDGAR |
SC 13D | 2023-11-06 | BIOTECHNOLOGY VALUE FUND L P | POINT Biopharma Global Inc. | 8,974,245 | 8.5% | EDGAR |
SC 13D/A | 2023-10-03 | SILBER ALLAN C | POINT Biopharma Global Inc. | 9,316,184 | 8.8% | EDGAR |
SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | POINT Biopharma Global Inc. | 4,916,306 | 4.7% | EDGAR |
SC 13G | 2023-02-03 | BlackRock Inc. | POINT Biopharma Global Inc. | 5,393,438 | 5.1% | EDGAR |
SC 13D/A | 2022-11-22 | SILBER ALLAN C | POINT Biopharma Global Inc. | 9,231,368 | 8.7% | EDGAR |
SC 13D/A | 2022-09-26 | RA CAPITAL MANAGEMENT, L.P. | POINT Biopharma Global Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2022-09-26 | BIOTECHNOLOGY VALUE FUND L P | POINT Biopharma Global Inc. | 2,991,213 | 2.9% | EDGAR |
SC 13D/A | 2022-09-16 | RA CAPITAL MANAGEMENT, L.P. | POINT Biopharma Global Inc. | 9,003,018 | 8.6% | EDGAR |
SC 13D/A | 2022-08-29 | RA CAPITAL MANAGEMENT, L.P. | POINT Biopharma Global Inc. | 9,003,018 | 9.9% | EDGAR |
SC 13G/A | 2022-02-15 | PERCEPTIVE ADVISORS LLC | POINT Biopharma Global Inc. | 1,193,995 | 1.3% | EDGAR |
SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | POINT Biopharma Global Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | POINT Biopharma Global Inc. | 1,504,826 | 1.7% | EDGAR |
SC 13G/A | 2022-02-14 | Boxer Capital, LLC | POINT Biopharma Global Inc. | 2,500,000 | 2.8% | EDGAR |
SC 13G/A | 2022-02-14 | RIVERVIEW GROUP LLC | POINT Biopharma Global Inc. | 5,207 | 0.0% | EDGAR |
SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | POINT Biopharma Global Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-11 | SUVRETTA CAPITAL MANAGEMENT, LLC | POINT Biopharma Global Inc. | 2,672,863 | 3.0% | EDGAR |
SC 13G/A | 2022-02-07 | FRANKLIN RESOURCES INC | POINT Biopharma Global Inc. | 773,700 | 0.9% | EDGAR |
SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | POINT Biopharma Global Inc. | 0 | 0.0% | EDGAR |